Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

You may be eligible if

• 16 -70 year olds
• A diagnosis of ulcerative colitis verified by colonoscopy or barium enema performed within 36 months prior to study entry
• Active disease despite ongoing treatment with IV steroids